Table 5.
Associations between jurisdiction-level percentage of emergency presentations and corresponding 1-year net survival
|
Oesophageal cancer |
Stomach cancer |
Colon cancer |
Rectal cancer |
Liver cancer |
Pancreatic cancer |
Lung cancer |
Ovarian cancer |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beta (95% CI) | p | Beta (95% CI) | p | Beta (95% CI) | p | Beta (95% CI) | p | Beta (95% CI) | p | Beta (95% CI) | p | Beta (95% CI) | p | Beta (95% CI) | p | |
| 10% increase in emergency presentations | 0·5% (−2·7 to 3·6) | 0·75 | −5·6% (−9·9 to −1·3) | 0·015 | −7·0% (−13·0 to −1·2) | 0·022 | 0·4% (−5·2 to 5·9) | 0·89 | −4·2% (−7·6 to −0·85) | 0·018 | −3·6% (−6·4 to −0·71) | 0·018 | −4·2% (−7·9 to −0·50) | 0·029 | −2·5% (−4·7 to −0·28) | 0·030 |
| R2 | 0·18 | .. | 0·36 | .. | 0·36 | .. | 0·02 | .. | 0·41 | .. | 0·34 | .. | 0·39 | .. | 0·29 | .. |
Beta values denote the percentage change in jurisdiction-level 1-year net survival associated with a 10% increase in jurisdiction-level percentage of emergency presentations. To maximise statistical power, jurisdiction-specific estimates were used in these models for New Brunswick, Nova Scotia, Prince Edward Island (part of Atlantic Canada in other analyses), and Manitoba and Saskatchewan (considered jointly in other analyses), therefore including estimates for 17 jurisdictions.